Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thyroxine synthesis is a complex multi-step biochemical pathway that occurs in thyroid follicular cells for the production of thyroid hormones T3 and T4. The process involves five main steps: (1) synthesis of thyroglobulin protein in the endoplasmic reticulum and its secretion into the follicular lumen, (2) active uptake of iodide from blood via the sodium-iodide symporter (NIS) and transport into the colloid via pendrin, (3) oxidation and organification of iodide by thyroid peroxidase (TPO) using hydrogen peroxide, followed by iodination of thyroglobulin tyrosine residues to form monoiodotyrosine (MIT) and diiodotyrosine (DIT), (4) coupling of iodinated tyrosines by TPO to generate T3 and T4 (T4 from two DITs, T3 from MIT and DIT), and (5) endocytosis of iodinated thyroglobulin, lysosomal proteolysis, and release of T3 and T4 into circulation. The entire process is regulated by thyroid-stimulating hormone (TSH) through the hypothalamic-pituitary-thyroid axis. This is a pathway involving multiple protein targets including NIS, pendrin, TPO, DUOX2, and thyroglobulin, rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroxine synthesis pathway.